Since cLIF cells exhibited a higher activity of SRC and consequently an enhanced EMT and invadopodia formation (Fig. 3), we therefore investigated whether treatment of cancer cells with AZD0530 alters LIF-regulated expressions of p-YAP1 and focal adhesion molecules, which might affect SRC activity. The gene discussed is SRC; the disease is cancer.